Toripalimab in Combined With Cetuximab ，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
Conditions: Squamous Cell Carcinoma of Head and Neck Interventions: Drug: Toripalimab Sponsors: First Affiliated Hospital of Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
A Study of IBI363 in Subjects With Advanced Melanoma
Conditions: Melanoma Interventions: Biological: IBI363 Sponsors: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Zanzalintinib; Drug: Zanzalintinib-matched Placebo; Biological: Pembrolizumab Sponsors: Exelixis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Penpulimab injection; Drug: cisplatin; Drug: albumin-paclitaxel Sponsors: Shanghai Ninth People ' s Hospital Affiliated to Shanghai Jiao Tong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy
Conditions: Skin Cancer; Melanoma Interventions: Other: AI assistance Sponsors: Karolinska University Hospital; Karolinska Institutet; Medical University of Vienna; Stockholm School of Economics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)
Conditions: Esophageal Squamous Cell Carcinoma (ESCC); PD-1 Inhibitors Interventions: Drug: IBI110+Sintilimab Sponsors: The First Affiliated Hospital of Zhengzhou University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Psychoeducation for Uveal Melanoma
Conditions: Uveal Melanoma Interventions: Behavioral: Education for Intervention; Behavioral: Best Practice Sponsors: Jonsson Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Locally Advanced Lung Carcinoma; Locally Advanced Malignant Solid Neoplasm; Locally Advanced Melanoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Stage III Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Other: Electronic Health Record Review Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study
Conditions: Uveal Melanoma Interventions: Other: Questionnaires and interviews Sponsors: Institut Curie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Conditions: Uveal Melanoma Interventions: Drug: Tebentafusp Sponsors: Diwakar Davar; Immunocore Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Molecular Characterization of Penile Cancers in Developing Countries
Conditions: Penile Squamous Cell Carcinoma Sponsors: Latin American Cooperative Oncology Group; Roche Pharma AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Conditions: Locally Advanced Alveolar Soft Part Sarcoma; Metastatic Alveolar Soft Part Sarcoma; Locally Advanced Non Small Cell Lung Cancer; Metastatic Non Small Cell Lung Cancer; Locally Advanced Small Cell Lung Cancer; Metastatic Small Cell Lung Cancer; Locally Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma; Locally Advanced Melanoma; Metastatic Melanoma Interventions: Drug: Atezolizumab Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Conditions: Metastatic Head-and-neck Squamous-cell Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma Interventions: Biological: Ficlatuzumab; Biological: Cetuximab; Other: Placebo Sponsors: AVEO Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: 1% Lugol ' s iodine solution; Drug: 5% Lugol ' s iodine solution Sponsors: Xijing Hospital of Digestive Diseases; Ankang Central Hospital; The First Affiliated Hospital of ShiheziI University; Xi ' an International Medical Center Hospital; Air Force 986 Hospital; Xianyang Central Hospital (the second people ' s Hospital of Xianyang City) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer
Conditions: Keratinocyte Skin Cancer Interventions: Device: Nevisense Sponsors: SciBase AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
